Novacyt

IT-IS International Ltd. is a UK-based company that develops and manufactures diagnostic instruments specifically for the life sciences and food testing sectors. Founded in 2004 and located in Stokesley, it specializes in mobile polymerase chain reaction (PCR) devices. The company, which was previously known as Innovative Technologies Innovative Solutions Limited until its name change in April 2005, is a subsidiary of Novacyt S.A. Through its focus on innovation in diagnostic technology, IT-IS International aims to enhance testing capabilities in its targeted industries.

Primerdesign Ltd. is a company based in Southampton, United Kingdom, specializing in the design, manufacture, validation, and supply of real-time PCR kits and reagents. Established in 2004, Primerdesign offers a wide range of products, including qPCR detection kits for human pathogens, food safety, veterinary testing, and biothreat detection, as well as genotyping kits. Their product offerings encompass primers, probes, mastermixes, reagents, and instruments, along with tools for DNA and RNA extraction. The company also provides research and development services, including consultancy and OEM opportunities, and has developed innovative solutions like the selective mastermix known as quasa, which enhances the specificity of allele-specific PCR. Primerdesign distributes its products directly and through a network of distributors both in the UK and internationally. The company has formed a strategic partnership with Biogazelle and operates as a subsidiary of Novacyt Société Anonyme.

Lab21 is a rapidly growing healthcare diagnostics business. The company’s vision is of providing personalised diagnostic testing for disease identification, disease predisposition and personalised medicine to protect people from the health problems of tomorrow. We believe that ‘prevention is better than cure’ and aim to provide information that helps to protect people from their health problems of tomorrow.Lab 21 Clinical Laboratory supports healthcare providers and the pharmaceutical and biotechnology industries with technically advanced testing services from its accredited facilities in Cambridge, UK. The Lab 21 team’s experience and know-how is coupled with a rapidly growing portfolio of molecular and viral diagnostics, plus next generation sequencing, pharmacogenetic and patient profiling tests, which all use cutting-edge technology. This unique combination adds value to pharmaceutical, diagnostic and biotech partners – and directly to clinicians or healthcare providers as they treat and monitor their patients.As we move towards truly personalised healthcare, the Lab 21 team contributes today – delivering high-quality information on drugs and patients that provides real clinical insight.

Centre de Compétences International en Tele-Imagerie designs and develops software suite for digital pathology.